<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Burkina Faso</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Burkina Faso.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/bf.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Heterogeneity of use, access, and retention of insecticide-treated nets: Implications for subnational tailoring to maximise malaria control</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-7554-elife-108745-4-d5839f7f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-7554-elife-108745-4-d5839f7f/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate that subnational variation in net use after access may be relevant when considering malaria-control deployment strategies. The abstract describes a framework for using routinely collected data to support subnational programme tailoring.</description>
    <category>Malaria</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Burden of Shigella infection in children under five years living in a peri-urban area of Ouagadougou, Burkina Faso: A community-based cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014624-0abee3ac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014624-0abee3ac/</guid>
    <pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate>
    <description>Regional incidence estimates and strain distributions offer foundational parameters for evaluating pediatric immunization strategies and directing sanitation resource allocation.</description>
    <category>Shigellosis</category>
    <category>Dysentery</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Antimicrobial resistance</category>
    <category>Diagnostics</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Maternal HIV viral load threshold for guiding extended infant prophylaxis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106779-e698d70a/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support a simplified risk-stratified approach to initiating extended infant postnatal prophylaxis, potentially enabling more targeted and resource-efficient prevention of mother-to-child HIV transmission during breastfeeding.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Cost-effectiveness analysis of a hypothetical vaccine for schistosomiasis in Madagascar and Burkina Faso</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128936-0b54e812/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128936-0b54e812/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The modeling results suggest that integrating adult demographics into future immunization campaigns could optimize resource allocation and disease reduction in highly affected regions. Policymakers might consider these economic parameters when planning next-generation preventive tools against this parasitic infection.</description>
    <category>Schistosomiasis</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Molecular detection of pathogens associated with childhood gastroenteritis in Burkina Faso using the FilmArray® GI panel</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14002-1-90e790a3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14002-1-90e790a3/</guid>
    <pubDate>Mon, 13 Jul 2026 00:00:00 GMT</pubDate>
    <description>The study describes pathogen distribution in childhood diarrhea in a low-income setting and reports that multiplex PCR testing supported broad pathogen detection in this population.</description>
    <category>Gastroenteritis</category>
    <category>Infectious Diarrhea</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Policy uptake and implementation of the RTS,S/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2023-014719-e90724cb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2023-014719-e90724cb/</guid>
    <pubDate>Tue, 30 Apr 2024 00:00:00 GMT</pubDate>
    <description>Twenty of thirty countries applying for vaccine support received financial approval from the Global Alliance for Vaccines and Immunization as of March 2024, demonstrating widespread interest. However, limited RTS,S/AS01 availability prevents some approved countries from receiving required doses, raising vaccine equity concerns.</description>
    <category>Malaria</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1811400-81a96cf1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1811400-81a96cf1/</guid>
    <pubDate>Thu, 06 Jun 2019 00:00:00 GMT</pubDate>
    <description>The trial addresses whether an added drug strategy could improve child outcomes during seasonal malaria chemoprevention in two African countries. The primary endpoint was serious illness or death, making the question relevant to child health and malaria-control programs.</description>
    <category>Malaria</category>
    <category>Trachoma</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Impact and effectiveness of pentavalent rotavirus vaccine in children &lt;5 years of age in Burkina Faso</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2017-12-056-a8edc181/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2017-12-056-a8edc181/</guid>
    <pubDate>Thu, 01 Nov 2018 00:00:00 GMT</pubDate>
    <description>The findings document the real-world impact of rotavirus vaccine in one of the first African countries to introduce RV5 nationally, demonstrating reductions in rotavirus-associated hospitalizations and supporting vaccine policy in similar settings.</description>
    <category>Gastroenteritis</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-13-30498-bf03c23f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-13-30498-bf03c23f/</guid>
    <pubDate>Thu, 30 Mar 2017 00:00:00 GMT</pubDate>
    <description>The study provides evidence on MERS-CoV circulation in African dromedary camel populations and identifies risk factors relevant to zoonotic transmission pathways from camels to humans.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>MERS</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Measles outbreak in Burkina Faso, 2009: A case–control study to determine risk factors and estimate vaccine effectiveness</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2012-05-024-3c82bb18/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2012-05-024-3c82bb18/</guid>
    <pubDate>Sun, 01 Jul 2012 00:00:00 GMT</pubDate>
    <description>The authors emphasize that findings support improved strategies to reduce missed vaccination opportunities and achieve high nationwide measles vaccination coverage to prevent large outbreaks and advance measles mortality reduction.</description>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
</channel>
</rss>
